Sleep Staging & Actigraphy

Navigation & Literature

• Parent Silo: 03 - Diagnostics & Quantified Self MOC
• Literature Dossier: Sleep Staging & Actigraphy - References

---

1. Reference Range Comparison (Standard Clinical vs. Longevity Optimal)

Sleep Telemetry Metric	Standard Clinical / AASM Range	Longevity / Functional Optimal	Primary Unit	Neurophysiological Function
Total Sleep Time (TST)	$7.0–9.0\text{ hours}$	$7.2–8.2\text{ hours}$ (actual asleep time, not time in bed)	$\text{Hours}$	Cumulative homeostatic and circadian neural/somatic restoration
Sleep Regularity Index (SRI)	Unmonitored ($60–75$)	$>85–90$ (Sleep/wake times within $\pm 15–30\text{ min}$ daily)	$\text{Index }(0–100)$	Stronger predictor of all-cause mortality than sleep duration alone (Windred et al. UK Biobank)
Sleep Efficiency ($\text{TST}/\text{TIB}$)	$>85\%$	$90–95\%$ (WASO $<20\text{ min}$)	$\%$	Continuity of sleep architecture without sympathetic micro-arousals
Sleep Onset Latency (SOL)	$10–20\text{ min}$	$10–18\text{ min}$ ($<5\text{ min}$ signals pathological sleep debt)	$\text{Minutes}$	Adenosine sleep pressure (Process S) + melatonin gate opening (Process C)
Slow-Wave Sleep (SWS / Stage N3)	$13–23\%$ ($55–90\text{ min}$)	$18–25\%$ ($80–120\text{ min}$)	$\%$ ($\text{Min}$)	High-amplitude EEG delta waves ($0.5–4\text{ Hz}$); glymphatic clearance, GH pulse, synaptic downscaling
REM Sleep (Rapid Eye Movement)	$20–25\%$ ($80–110\text{ min}$)	$22–25\%$ ($95–125\text{ min}$)	$\%$ ($\text{Min}$)	Cholinergic/theta dreaming state; amygdala emotional overnight therapy & procedural memory integration
Nocturnal Skin Temp Deviation	$\pm 0.3^{\circ }\text{C}$	$-0.2\text{ to }+0.1^{\circ }\text{C}$ vs. baseline	${}^{\circ }\text{C}$	Distal vasodilation reflects core body temperature drop ($-1.0^{\circ }\text{C}$) required for SWS
Apnea-Hypopnea Index (AHI) / ${\text{SpO}}_2$	$\text{AHI}<5\text{/hr}$	$\text{AHI}<1–2\text{/hr}$	${\text{Mean SpO}}_2\ge 96\%$ ($\text{ODI}<1$)	$\text{Events/hr},\%$

---

2. Physiological Significance & Sensor Accuracy Architecture

Polysomnography (PSG) vs. Forehead EEG vs. Multi-Sensor PPG/Actigraphy Wearables

Understanding the physical signal captured by a wearable prevents over-reacting to algorithmic staging artifacts:

1. Gold-Standard Laboratory Polysomnography (PSG): Directly measures cortical brainwaves (EEG), eye movements (EOG), submental muscle atonia (EMG), ECG, nasal airflow, and ${\text{SpO}}_2$.
2. At-Home Dry-Electrode EEG Headbands (Dreem, Muse S, Elemind, Somnee): Measure true frontal/occipital cortical EEG delta ($0.5–4\text{ Hz}$), theta ($4–8\text{ Hz}$), alpha, and sleep spindles ($11–16\text{ Hz}$), achieving $83–88\%$ 4-stage agreement ($\text{Cohen’s }\kappa \approx 0.75–0.80$) with clinical PSG—comparable to inter-scorer human technician agreement.
3. Peripheral Multi-Sensor Wearables (Oura Ring Gen 3/4, Whoop 4.0, Eight Sleep Pod, Apple Watch): Do not measure brainwaves. They infer sleep stages via machine-learning models trained on 3-axis accelerometry (actigraphy) + photoplethysmography (PPG heart rate, IBI/HRV, respiratory rate) + peripheral temperature:
   • Sleep vs. Wake Detection: Exceptionally accurate ($91–95\%$ sensitivity, $89–92\%$ overall accuracy).
   • 4-Stage Classification (Wake, Light N1/N2, Deep N3, REM): Modern algorithms (Oura Gen 3/4, Apple Watch, Eight Sleep) achieve $75–80\%$ 4-stage agreement ($\kappa \approx 0.65–0.70$) against PSG. Because peripheral wearables rely heavily on autonomic stabilization (low HR, regular respiration, zero movement) to call Deep Sleep (N3) and high autonomic variability (fluctuating HR/respiration, zero movement) to call REM, alcohol or late meals—which artificially distort nocturnal HRV—can cause wearables to misclassify N3 vs. Light sleep even beyond the true EEG suppression.

The Glymphatic Clearance Engine & The Sleep Regularity Mortality Curve

• Glymphatic Convexity (Xie & Nedergaard): During Slow-Wave Sleep (N3), locus coeruleus noradrenergic tone drops to near zero, causing brain interstitial space volume to expand by 60%. Synchronized slow delta waves ($0.5–4\text{ Hz}$) drive pulsatile cerebrospinal fluid (CSF) influx through astrocytic Aquaporin-4 (AQP4) water channels, clearing amyloid-$\beta$, hyperphosphorylated tau, and $\alpha$-synuclein at twice the waking rate. Even a single night of SWS deprivation acutely increases human CSF and hippocampal amyloid-$\beta$ burden by 5–10% (Shokri-Kojori et al., PNAS).
• Sleep Regularity Supersedes Sleep Duration (Windred et al., Sleep 2024): In a prospective UK Biobank actigraphy analysis ($N=60,977$, $>10\text{ million}$ hours of accelerometer data), the Sleep Regularity Index (SRI)—going to bed and waking up at consistent times across weekdays and weekends—was a stronger predictor of all-cause, cancer, and cardiometabolic mortality than sleep duration. Individuals in the top quintile of sleep regularity had a 20–48% lower hazard of all-cause mortality ($\text{HR }0.52–0.80$) than irregular sleepers, even after adjusting for total hours slept.

---

3. Root Causes of SWS & REM Suppression

• Slow-Wave Sleep (N3) Destroyers (First Half of Night):
  • Elevated Core Body Temperature: A warm bedroom ($>21^{\circ }\text{C}$), heavy duvet, late-night intense exercise, or late heavy meal prevents the mandatory $-1.0^{\circ }\text{C}$ drop in core body temperature required by preoptic anterior hypothalamic (POAH) warm-sensitive neurons to initiate N3 delta waves.
  • Late Caffeine & Adenosine Blockade: Consuming caffeine within 8–10 hours of sleep blocks $A_1/A_{2A}$ receptors and reduces EEG slow-wave delta power by 15–25% even when sleep onset feels normal.
• REM Sleep Destroyers (Second Half of Night):
  • Alcohol & THC (Cannabis): Both act as sedatives that fragment the second half of the night and potently suppress cholinergic REM sleep via aldehyde/CB1 signaling.
  • Alarm Clock Truncation (“Sleep Bulimia”): Because 60–70% of total nightly REM sleep occurs in the final two 90-minute ultradian cycles (04:30–07:00 AM), cutting an 8-hour sleep requirement down to 6 hours cuts total sleep by 25% but destroys 50–70% of REM sleep.

---

4. Actionable Interventions

Foundational Protocols (01 - Foundations)

• Thermal Chronobiology (Mattress Cooling + Warm Bath Paradox):
  • Set active hydro-cooling mattress systems (Eight Sleep) to $-2\text{ to }-4^{\circ }\text{C}$ ($18–19^{\circ }\text{C}$ surface equivalent) during the Deep Sleep window (hours 0–4) to accelerate core heat dumping, then warm slightly ($+1^{\circ }\text{C}$) during the REM window (hours 4–7) (thermoneutrality prevents thermoregulatory shivering/sweating during REM muscle atonia) per Sleep Environment & Hygiene and Sleep Architecture.
  • Taking a $40–42^{\circ }\text{C}$ hot bath or sauna for 20 minutes $60–90\text{ minutes}$ before bed triggers peripheral cutaneous vasodilation (glabrous skin of hands/feet), accelerating core body temperature drop and reducing sleep latency by 36% while boosting SWS (Haghayegh et al.).
• Bedroom ${\text{CO}}_2$ Ventilation ($<800\text{ ppm}$): Closed bedrooms rapidly accumulate exhaled ${\text{CO}}_2$ to $1,800–3,000\text{ ppm}$ overnight, triggering brainstem chemoreceptor micro-arousals, reducing Deep N3 sleep, and impairing next-day cognitive executive function by 15–50% (Strøm-Tejsen et al.). Crack a window or run ERV ventilation to hold ${\text{CO}}_2<800\text{ ppm}$.
• Anchor the Sleep Regularity Index ($\text{SRI}>85$): Keep wake time and bedtime within a strict $\pm 30\text{ minute}$ window 7 days/week per Circadian Entrainment & Zeitgebers.

Molecular & Pharmacological Interventions (02 - Compounds & Molecules)

• Slow-Wave Sleep & Thermoregulatory Stack (Taken 60 Min Pre-Bed):
  • Glycine ($3\text{ g}$): Binds NMDA receptors in the suprachiasmatic nucleus (SCN) to induce peripheral cutaneous vasodilation, dropping core body temperature and accelerating entry into Stage N3 SWS without altering architecture via Sleep Supplementation & Pharmacology and Amino Acids & Precursors.
  • Magnesium L-Threonate ($144\text{ mg}$ elemental) or Magnesium Bisglycinate ($200–300\text{ mg}$): Enhances ${\text{GABA}}_A$ receptor affinity and blocks NMDA glutamate excitotoxicity (Magnesium Forms & Bioavailability).
  • Apigenin ($50\text{ mg}$), L-Theanine ($200\text{ mg}$), and Myo-Inositol ($900–2000\text{ mg}$): Reduce nocturnal awakenings and enhance REM/SWS continuity.
• Pineal Peptides (for Age-Related SWS/Melatonin Decline): Epitalon and DSIP (Delta Sleep-Inducing Peptide) via Khavinson Bioregulators (Epitalon, Pinealon).

---

5. Key Scientific Evidence Summary

• Windred et al. (2024, Sleep): Objective UK Biobank accelerometer cohort ($n=60,977$; $>10\text{M}$ hours) proving Sleep Regularity Index (SRI) is a stronger predictor of all-cause mortality ($\text{HR }0.52–0.80$) than sleep duration.
• Xie et al. (2013, Science) & Shokri-Kojori et al. (2018, PNAS): Established the SWS-driven glymphatic clearance system (60% interstitial expansion) and proved via human PET imaging that a single night of sleep deprivation increases human brain $\beta$-amyloid burden in the hippocampus and thalamus.
• Chinoy et al. (2021, Sleep) & Svensson et al. (2024, Sleep Medicine): Benchmarked multi-sensor consumer wearables (Oura Ring Gen 3, Whoop, Apple Watch) and EEG headbands against laboratory PSG.
• Strøm-Tejsen et al. (2016, Indoor Air): Randomized crossover trial proving that lowering bedroom ${\text{CO}}_2$ from $2,395\text{ ppm}$ to $715\text{ ppm}$ significantly improves objective actigraphic sleep efficiency, sleep depth, and next-day logical cognitive performance.

See full bibliographic details and quantitative effect sizes in Sleep Staging & Actigraphy - References.